Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
33.72
+1.23 (3.79%)
At close: Mar 6, 2026

SHA:688076 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
404.39162.94129.11115.39
Depreciation & Amortization
209.29135.5599.9684.77
Other Amortization
7.734.614.724.25
Loss (Gain) From Sale of Assets
-0.5-0.18-18.89-0.06
Asset Writedown & Restructuring Costs
9.715.30.452.31
Loss (Gain) From Sale of Investments
1.72-3.16-19.98-3.22
Provision & Write-off of Bad Debts
20.625.115.871.65
Other Operating Activities
58.164929.6315.44
Change in Accounts Receivable
-348.97-126.49-145.04-45.88
Change in Inventory
-243.29-82.58-111.74-87.63
Change in Accounts Payable
291.17180.3858.3475.82
Change in Other Net Operating Assets
32.6323.31.718.77
Operating Cash Flow
400.12350.2129.29180.75
Operating Cash Flow Growth
14.25%1095.59%-83.79%27.84%
Capital Expenditures
-1,090-660.64-438.36-233.36
Sale of Property, Plant & Equipment
3.981.530.060.34
Divestitures
--13.12-
Investment in Securities
-308-6-25.95-7
Other Investing Activities
0.952.91.393.09
Investing Cash Flow
-1,393-662.21-449.74-236.93
Short-Term Debt Issued
---242.68
Long-Term Debt Issued
1,6981,146388.99-
Total Debt Issued
1,6981,146388.99242.68
Short-Term Debt Repaid
----422.79
Long-Term Debt Repaid
-901.76-454.73-129.65-4.11
Total Debt Repaid
-901.76-454.73-129.65-426.91
Net Debt Issued (Repaid)
796.43691.05259.34-184.23
Issuance of Common Stock
22.98--762.63
Common Dividends Paid
-118.75-57.61-40.57-6.04
Dividends Paid
-118.75-57.61-40.57-6.04
Other Financing Activities
99.1-1.5418.15-37.47
Financing Cash Flow
799.75631.9236.91534.89
Foreign Exchange Rate Adjustments
8.34-3.21-0.82-1.58
Net Cash Flow
-184.98316.69-184.35477.13
Free Cash Flow
-690.01-310.43-409.07-52.61
Free Cash Flow Margin
-42.47%-30.04%-62.81%-8.17%
Free Cash Flow Per Share
-2.24-1.03-1.38-0.20
Cash Income Tax Paid
18.568.2-29.3-11.18
Levered Free Cash Flow
-856.88-374.23-441.9-133.86
Unlevered Free Cash Flow
-835.17-364.18-436.11-130.04
Change in Working Capital
-311-18.95-201.59-39.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.